期刊文献+

IL-1RA对大鼠角膜移植免疫排斥反应的抑制作用 被引量:3

The effects of IL-1RA on penetrating keratoplasty rejection in rat
下载PDF
导出
摘要 目的研究白细胞介素-1受体拮抗剂( IL-IRA)对大鼠角膜移植排斥反应的防治作用。方法建立大鼠穿透角膜移植排斥反应的动物模型,观察IL-IRA对大鼠角膜植片存活和排斥反应指数( RI)的影响,并与阴性对照组和环抱霉素 A(CsA)治疗组相比较。结果阴性对照组角膜植片平均存活时间为 12. 235天± 1. 674天,而 CsA治疗组为17.676天±1.528天,IL-1RA治疗组为19.250天±1.456天,均比阴性对照组显著延长(P<0.01);IL-1RA治疗组角膜植片新生血管指数明显低于对照组和CsA治疗组(P<0.01)。结论IL-1RA能抑制大鼠穿透角膜移植免疫排斥反应,显著地延长角膜植片的存活时间,并具有抑制角膜植片新生血管生长的作用。 Objective To study the efficacy of immunosuppressant IL-lRA on the rat model of penetrating keratoplasty. Methods Comeal transplantation were performed orthotopically from Lou rats to F344 rat rat' s recipients. Animals were randomly assigned to the following groups: 1. Control. 2. CsA (3mg/kg/2d, subconjunctival injection ). 3. IL-l RA (0. 5mg/kg/2d, subconjunctival injection). Treatment began at the l st day postoperatively and continued until the 14th day postoperatively. Mean survival times and rejection index were determined. Results The mean survival time of the control group was 12. 235 ± 1. 674 days, but the mean survival time for CsA and IL-l RA were 17. 676 ± 1. 528 days and 19. 250 ± 1. 456 days, respectively, which was statistically significant compared with the control group(P < 0. 01). Vascularization index in IL-RA group was markedly lower when compared with the control and CsA groups(P < 0. 01 ). Conclusion IL-lRA can markedly prolong the survival time of comeal allografts by inhibiting graft rejection, and prevent vascular growth of comeal allografts.
出处 《眼科研究》 CSCD 北大核心 2001年第3期195-198,共4页 Chinese Ophthalmic Research
关键词 角膜移植 移植物免疫排斥 白细胞介素一1受体拮抗剂 keratoplasty graft rejection IL-1RA
  • 相关文献

参考文献1

二级参考文献1

共引文献6

同被引文献21

  • 1廖琼,刘翔.IL-1受体拮抗剂防治大鼠角膜移植排斥反应的实验研究[J].眼科新进展,2004,24(5):364-365. 被引量:1
  • 2袁进,陈家祺,刘祖国,王智崇,周世有.IL-1ra基因修饰角膜内皮细胞及其表达[J].眼科新进展,2006,26(1):2-6. 被引量:4
  • 3Wilson SE, Wilcox CJ, Arend WP, Streilein JW. In vivo antigenic activity of interleukins[ J]. Invest Ophthalmol Vis Sci 1992;33:1756-1765.
  • 4Dana MR, Zhu SN, Yamada J. Topical modulation of interleukin-1 activity in corneal neovasculerization [ J ].Cornea 1998; 17(4) :403-409.
  • 5Larkin DFP, Calder VL, Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection [ J ]. Clin Exp Immunol 1997; 107: 381-391.
  • 6Okadak K, Sakata H, Minamoto A. Effect of FK-506 aministered of the corneal immune reaction in rats [ J ]. Ophthalmologica 1996; 210:175.
  • 7Coster DJ. Mechamisms of corneal graft failure; the erosion of corneal privilege[J]. Eye, 1989, 3(2): 151-3.
  • 8Apel A, Oh C, Chiu R, et al. A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy[J]. Curr Eye Res, 1995, 14(8): 659-67.
  • 9Larkin DFP, Calder VL, Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection[J]. Clin Exp Immunol, 1997, 107(2): 381-91.
  • 10Dana MR, Zhu SN, Yamada J. Topical modulation ofinterleukin-1 activity in corneal neovascularization [J]. Cornea, 1998, 17(4): 403-9.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部